PD-L1 inhibitor (unspecified)
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for PD-L1 inhibitor (unspecified), covering 2025-05-28 to 2026-04-23. Get the full timeline:
Most recent: Clinical Trial Update: MEK Inhibitor and a PDL1 Inhibitor Patients With Locally Advanced and/or Metastatic Soft Tissue Sarcoma [Phase 1, Phase 2]